Accel Research Sites’ CEO interviewed by Orlando Business Journal on company’s growth - Alcanza Clinical Research

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 09/07/2021

Accel Research Sites’ CEO interviewed by Orlando Business Journal on company’s growth

With demand for COVID vaccines and treatment continuing in 2021, Accel Research Sites has stayed on the cutting edge of growth.

Not only expanding options for patients and participants, but also expanding the company.

Orlando Business Journal recently interviewed Accel’s CEO, Lora Parahovnik, on how the company has adjusted to thrive over the last year and plans for growth.

Learn more here.

Back

Articles

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height